Colonic delivery of nicotine to treat inflammatory bowel disease
US5889028A · kind A · utility
146Cited by
13References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 7, 1997 |
| Grant date | Mar 30, 1999 |
| Priority date | — |
| Expiry date | Aug 7, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0031
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is provided to treat inflammatory bowel disease by locally administering to the colon an effective amount of nicotine or a pharmaceutically acceptable salt thereof, preferably via formulations adapted for delayed oral release or rectal administration. Further provided is a novel formulation for the oral administration of nicotine comprising a polyacrylic polymer complexed with nicotine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.